Biolase Inc.&Galena Biopharma Inc. News and Reports: (NASDAQ:BIOL), (NASDAQ:GALE)
BIOLASE, Inc. (NASDAQ:BIOL) announced that the U.S. Food and Drug Administration (FDA) has cleared the EPIC 10S™ soft tissue diode laser for use as a surgical instrument for over 80 different indications in 19 medical markets including: ear, nose and throat, oral surgery, arthroscopy, gastroenterology, orthopedics, general surgery, dermatology, plastic surgery, podiatry, GI/GU, gynecology, neurosurgery, ophthalmology, pulmonary surgery, cardiac surgery, thoracic surgery, urology, dermatology, aesthetics, and vascular surgery.
View full press release